Huntington Bancshares (NASDAQ:HBAN – Get Rating) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Wednesday.

ManpowerGroup (NYSE:MAN – Get Rating) had its price objective cut by stock analysts at BMO Capital Markets from $133.00 to $116.00 in a note issued to investors on Thursday, Benzinga reports. The firm presently has an “outperform” rating on the business services provider’s stock. BMO Capital Markets’ target price suggests a potential upside of 30.93% from the company’s current price.

Brokerages expect Teradyne, Inc. (NASDAQ:TER – Get Rating) to announce sales of $744.03 million for the current fiscal quarter, Zacks reports. Four analysts have issued estimates for Teradyne’s earnings, with the lowest sales estimate coming in at $731.00 million and the highest estimate coming in at $765.00 million. Teradyne reported sales of $781.61 million in the same quarter last year, which indicates a negative year-over-year growth rate of 4.8%. The company is expected to issue its next quarterly earnings results on Monday, January 1st.

Boston Beer (NYSE:SAM – Get Rating) is set to post its quarterly earnings results after the market closes on Thursday, April 21st. Analysts expect Boston Beer to post earnings of $2.13 per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

Equities analysts expect Visteon Co. (NASDAQ:VC – Get Rating) to post $726.07 million in sales for the current fiscal quarter, according to Zacks Investment Research. Five analysts have made estimates for Visteon’s earnings, with the lowest sales estimate coming in at $691.00 million and the highest estimate coming in at $755.17 million. Visteon posted sales of $746.00 million during the same quarter last year, which suggests a negative year over year growth rate of 2.7%. The firm is scheduled to announce its next earnings report on Monday, January 1st.

ExlService (NASDAQ:EXLS – Get Rating) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Thursday.

Wall Street brokerages expect that Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Rating) will post $10.64 million in sales for the current quarter, Zacks Investment Research reports. Four analysts have provided estimates for Y-mAbs Therapeutics’ earnings. The highest sales estimate is $11.51 million and the lowest is $9.96 million. Y-mAbs Therapeutics posted sales of $5.38 million during the same quarter last year, which would suggest a positive year over year growth rate of 97.8%. The firm is expected to issue its next earnings results on Monday, January 1st.

Williams-Sonoma (NYSE:WSM – Get Rating) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a report released on Tuesday.

International Business Machines (NYSE:IBM – Get Rating) will release its earnings data after the market closes on Tuesday, April 19th. Analysts expect International Business Machines to post earnings of $1.35 per share for the quarter.

PDC Energy, Inc. (NASDAQ:PDCE – Get Rating) – Investment analysts at Capital One Financial lifted their Q1 2022 earnings per share estimates for shares of PDC Energy in a note issued to investors on Sunday, April 10th. Capital One Financial analyst B. Velie now anticipates that the energy producer will post earnings of $2.96 per share for the quarter, up from their prior estimate of $2.84. Capital One Financial also issued estimates for PDC Energy’s Q2 2022 earnings at $3.71 EPS, Q3 2022 earnings at $4.22 EPS, Q4 2022 earnings at $4.67 EPS, FY2022 earnings at $15.56 EPS and FY2023 earnings at $18.35 EPS.